Health Economic Aspects of Chimeric Antigen Receptor T-cell Therapies for Hematological Cancers: Present and Future
Renaud Heine(Erasmus University Rotterdam), Carin A. Uyl‐de Groot(Erasmus University Rotterdam), Carin Smand(European Hematology Association), Jorge Sierra(Universitat Autònoma de Barcelona), Marie José Kersten(Hovon), Marc Koopmanschap(Erasmus University Rotterdam), Frederick W. Thielen(University Medical Center Freiburg), Pieter Sonneveld(Erasmus MC Cancer Institute), Ulrich Jaeger(Medical University of Vienna), Hermann Einsele(Universitätsklinikum Würzburg)
Cited by 52
Related Papers
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
International uniform response criteria for multiple myeloma
|Leukemia|2006|2.6k